RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo

Pancreatic neuroendocrine tumors (pNETs) are difficult-to-treat neoplasms whose incidence is rising. Greater understanding of pNET pathogenesis is needed to identify new biomarkers and targets for improved therapy. RABL6A, a novel oncogenic GTPase, is highly expressed in patient pNETs and required f...

Descripción completa

Detalles Bibliográficos
Autores principales: Maharjan, Chandra K., Umesalma, Shaikamjad, Kaemmer, Courtney A., Muniz, Viviane P., Bauchle, Casey, Mott, Sarah L., Zamba, K. D., Breheny, Patrick, Leidinger, Mariah R., Darbro, Benjamin W., Stephens, Samuel B., Meyerholz, David K., Quelle, Dawn E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228095/
https://www.ncbi.nlm.nih.gov/pubmed/34199469
http://dx.doi.org/10.3390/biomedicines9060633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228095/
https://www.ncbi.nlm.nih.gov/pubmed/34199469
http://dx.doi.org/10.3390/biomedicines9060633

Ejemplares similares